SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027289
Filing Date
2018-11-06
Accepted
2018-11-06 14:23:43
Documents
66
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akca-10q_20180930.htm 10-Q 2321131
2 EX-10.1 akca-ex101_90.htm EX-10.1 790029
3 EX-31.1 akca-ex311_8.htm EX-31.1 18997
4 EX-31.2 akca-ex312_6.htm EX-31.2 18988
5 EX-32.1 akca-ex321_7.htm EX-32.1 10872
  Complete submission text file 0001564590-18-027289.txt   9435502

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT akca-20180930.xml EX-101.INS 2078163
7 XBRL TAXONOMY EXTENSION SCHEMA akca-20180930.xsd EX-101.SCH 60667
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20180930_cal.xml EX-101.CAL 48905
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20180930_def.xml EX-101.DEF 247792
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20180930_lab.xml EX-101.LAB 427021
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20180930_pre.xml EX-101.PRE 340798
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 181162543
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1